Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $1.15 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $1.15B.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $1.18B.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $926.35M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $981.39M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value as first filed |
|---|---|---|
| 2026-06-30 | $1.15B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $1.18B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $926.35M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $981.39M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.14B 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $1.09B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.18B 10-Q · filed 2025-05-08 | $545.40M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $560.79M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $505.04M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.09B 10-Q · filed 2025-05-08 | $503.66M 10-K · filed 2024-02-28 |
| 2023-09-30 | $411.86M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $224.98M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $254.93M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $301.75M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $337.45M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $346.21M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $174.18M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $133.01M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $77.79M 10-K · filed 2022-03-30 |